Table 2.
Characteristics of the cases for HBV antigen-specific T cell response
| N | Healthy vaccine | Chronic hepatitis | Self-limited | ALF-OLT | LC-OLT-good | LC-OLT-poor |
|---|---|---|---|---|---|---|
| 11 | 10 | 5 | 4 | 8 | 7 | |
| Age | 29 (28–31) | 53 (42.5–61) | 67 (58.5–77) | 41.5 (37.2–47.2) | 60 (53–62) | 55 (40–58) |
| Sex [M (%)] | 10 (91) | 7 (70) | 2 (40) | 0 (0) | 8 (100) | 7 (100) |
| HBs Ag (+) | 0 | 10 [titer 2000 (1893–2000)] | 0 | 0 | 0 | 0 |
| HBs Ab (IU/l) (>100/≤100) | 8/3 | 0/10 | 2/3 | 2/2 | 4/4 | 1/6 |
LC-OLT-poor patients received HBIG within 3 months
Age and HBsAg were shown as median (interquartile range)
ALF-OLT acute liver failure patients who received OLT, LC-OLT-good liver cirhosis patients who received OLT and had a good vaccine response, LC-OLT-poor liver cirrhosis patients who received OLT and had a poor vaccine response